You are here

05-10-2018

3118Challenging Einstein’s theory about gravity in deep space

ERC grantee Dr Kazuya Koyama, originally from Japan, tests gravity, specifically whether Albert Einstein’s general theory of relativity can be applied beyond our solar system. At present general relativity works in our galaxy but is less convincing at the far borders of our universe which is rapidly expanding and needs weird energy to explain this. Dr Koyama is hoping that observations in deep space will show that the theory can be modified to work on a larger scale so that this strange 'dark energy' is not needed – removing one of cosmology's biggest mysteries.

On the occasion of the signing of a new agreement with the Japanese Science and Technology Agency to encourage top Japanese researchers to temporarily join ERC-funded teams in Europe, the ERC interviewed Dr Kazuya Koyama about his international career and how he believes this helps strengthen scientific partnerships between researchers in Europe and Japan.

28-09-2018

3110Making sense of commitment

An EU-funded project is exploring what keeps people committed to a task even when they get bored, distracted or are tempted to stop. The findings could foster productivity-boosting strategies, improve robot-human interactions and even help treat borderline personality disorder.

27-08-2018

3029From basic research to clinical medicine: stimulating the natural growth of heart blood vessels

At the forefront of medicine, gene therapy is based on the insertion of genes into an individual's cells and tissues to treat a disease. Scientists are currently testing several approaches to this experimental technique. One of them, Prof. Seppo Ylä-Herttuala, intends to develop a novel method to treat myocardial ischemia by activating endogenous genes to propel angiogenesis. If successful, he will open a new era in gene therapy.

20-08-2018

3027Artificial heart valves: synthetic polymer coatings could reduce complications in patients

More than 100 million people worldwide suffer from valvular heart disease, affecting one or more of the heart’s four valves and causing breathlessness, chest pain, dizziness and fainting. If severe valvular heart disease is not properly treated, chances of surviving decrease, especially in the elderly. The only effective therapy is heart valve replacement, which may entail some risks and lead to revision surgeries. What can be done to improve safety and durability of artificial heart valves? 

10-07-2018

2956Microrobots for improved eye surgery

Originally published in May 2015

Updated in July 2018

With an aging population, Europe sees a rapid increase in the number of people affected by visual disorders requiring surgical intervention. Building on the recent advances in robotic assistance in surgery as well as in precisely targeted drug delivery therapies, Prof. Bradley Nelson has designed innovative microrobotics tools to overcome the particular difficulty of manual-performed eye surgery.

29-06-2018

2934Organoids to treat liver diseases

Cell transplantation is a promising new approach for organ regeneration in disease or after injury. To support the differentiation of hepatocytes from stem cells, European researchers developed ex vivo organoids which precisely mimic liver architecture.

29-05-2018

2896Shut up and heal - possible strategy to cure sick livers

'Silent killers'. This is how liver diseases are often described. But, are they really that silent? ERC grantee Mathieu Vinken, a pharmacist by training and worldwide expert in toxicology based at Vrije Universiteit Brussel (VUB), has just proven the contrary.

17-04-2018

2826Addressing the complexity of road traffic networks

Everyone who has ever been stuck in traffic knows how frustrating and time-wasting it can be. ERC grantee Carlos Canudas de Wit is working on a global approach to improve traffic management systems using the new technologies and innovations that have not yet been fully exploited.

11-10-2017

2590Le cerveau du bébé, comme jamais vu auparavant

Pour la toute première fois, une équipe de scientifiques et des cliniciens dirigée par le chercheur Mickael Tanter, financé par l'UE, a réussi à enregistrer l'activité cérébrale d'un nouveau-né prématuré en phase de repos et lors d'une crise d'épilepsie. À l'aide d'une technologie d'échographie non invasive, cette première mondiale marque un véritable tournant dans le domaine de la recherche et la pratique médicale. Elle offre par ailleurs une vaste gamme d'applications en neuroimagerie et au-delà. L'étude est publiée aujourd'hui dans Science Translational Medicine.

11-10-2017

2589The baby's brain, as never seen before

For the first time ever, a team of scientists and clinicians led by the EU-funded researcher Mickael Tanter has managed to record the brain activity of a premature new-born baby during resting and during an epileptic seizure. Using a non-invasive ultrasound technology, this world premiere is a real game changer for researchers and the medical profession, offering a massive range of applications in neuroimaging and beyond. It is published today in Science Translational Medicine.